Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2022 | De-escalation of therapy in early-stage TNBC

Oleg Gluz, MD, Evang. Krankenhaus “”Bethesda”” Klinik, Mönchengladbach, Germany, talks on treatment de-escalation approaches in triple-negative breast cancer (TNBC), highlighting the role of clinical markers, sensitivity to chemotherapy and the immune microenvironment can help guide decision-making in early TNBC. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.